Valeant Pharma Acquires Salix
Tuesday, March 17, 2015 3:00 PM EDT
Valeant Pharmaceuticals beat out Endo International in a battle to take over Salix Pharmaceuticals in a deal valued at $11.1 billion. Valeant had originally agreed to pay $158 per share of Salix but increased the offer to $178 per share.
In this article: VRX